| 英文别名 |
Benzeneacetamide, a-methyl-4-(2-methylpropyl)-;rac-Ibuprofen Amide;(2RS)-2-[4-(2-Methylpropyl)phenyl]propanamide;2-(4-isobutylphenyl)propanamide;2-[4-(2-methylpropyl)phenyl]propanamide;α-Methyl-4-(2-methylpropyl)benzeneacetamide;(±)-Ibuprofen amide;Ibuprofen impurity C (PhEur);4-isobutyl-alpha-methylphenylacetamide;IBUPROFEN IMPURITY C [EP IMPURITY];BRD-A57554269-001-01-9;(+/-)-IBUPROFENAMIDE;(2RS)-2-(4-(2-METHYLPROPYL)PHENYL)PROPANAMIDE;BENZENEACETAMIDE, .ALPHA.-METHYL-4-(2-METHYLPROPYL)-;AS-76769;74M0104F2J;Maybridge1_008183;AKOS022099909;REUQKCDCQVNKLW-UHFFFAOYSA-N;2-(4-Isobutylphenyl)propanoic amide;CHEMBL4754893;2-(p-Isobutylphenyl)propionamide;Benzeneacetamide, alpha-methyl-4-(2-methylpropyl)-;(2RS)-2-(4-Isobutylphenyl)propionamide;IBUPROFENAMIDE, (+/-)-;SB77911;Q27266290;2-(4-Isobutylphenyl)propionamide;2-[4-(Isobutyl)phenyl]propionamide;Cambridge id 5106625;Propionamide, 2-(p-isobutylphenyl)-;.ALPHA.-METHYL-4-(2-METHYLPROPYL)BENZENEACETAMIDE;F19290;SR-01000642360-1;RAC-IBUPROFEN AMIDE;2-[4-(2-Methylpropyl)phenyl]propanimidic acid;NIOSH/UE4469300;BDBM50551699;UE44693000;SCHEMBL260688;(2RS)-2-(4-Isobutylphenyl)propionamide, pharmaceutical impurity standard;CCG-53179;HMS564L21;(R)-2-(4-Isobutyl-phenyl)-propionamide;NS00056571;Ibuprofenamide;FT-0608652;DTXSID10974925;EINECS 261-793-9;(2RS)-2-[4-(2-Methylpropyl)phenyl]propanamide; Ibuprofen Imp. C (EP); Ibuprofen Impurity C;MFCD00454181;CS-0154061;UNII-74M0104F2J;59512-17-3;2-(4-isobutyl-phenyl)-propionamide;Ibuprofen Imp. C : (2RS)-2-[4-(Methylpropyl)-phenyl]propanamide |